James Kashugyera Tumwine

James Kashugyera Tumwine

Auto-generated profile, based on publicly available information

James Kashugyera Tumwine

School of Medicine, Kabale University, Kampala, Uganda

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2010 in Reproductive Health
Verified
Journal Article
Open access
PDF file
RBRobert Byamugisha
Robert Byamugisha
JTJames K Tumwine
James K Tumwine
NSNulu Semiyaga
Nulu Semiyaga
Thorkild TylleskärThorkild Tylleskär
Thorkild Tylleskär
Mother-to-child transmission of HIV (MTCT) accounts for over 95% of all paediatric HIV infections worldwide. Several studies have shown that male participation in the antenatal care of their spouses together with couple counselling and testing for HIV, increases use of the interventions for HIV prevention. The prevention programme of MTCT (PMTCT) was launched in Uganda in 2000 and Mbale in 2002. Less than 10% of the pregnant women accepted antenatal HIV testing at Mbale Regional Referral Hospital in 2003; couple counselling and testing for HIV was low. Therefore, we conducted the study to determine the level of male involvement and identify its determinants in the PMTCT programme.

1 January 2011 in Journal of the International AIDS Society
Verified
Journal Article
Open access
PDF file
RBRobert Byamugisha
Robert Byamugisha
AÅAnne N Åstrøm
Anne N Åstrøm
GNGrace Ndeezi
Grace Ndeezi
CKCharles As Karamagi
Charles As Karamagi
Thorkild TylleskärThorkild Tylleskär
Thorkild Tylleskär
JTJames K Tumwine
James K Tumwine
Background: The objective of the study was to evaluate the effect of a written invitation letter to the spouses of new antenatal clinic attendees on attendance by couples and on male partner acceptance of HIV testing at subsequent antenatal clinic visits.Methods: The trial was conducted with 1060 new attendees from October 2009 to February 2010 in an antenatal clinic at Mbale Regional Referral Hospital, Mbale District, eastern Uganda. The intervention comprised an invitation letter delivered to the spouses of new antenatal attendees, while the control group received an information letter, a leaflet, concerning antenatal care. The primary outcome measure was the proportion of pregnant women who attended antenatal care with their male partners during a follow‐up period of four weeks. Eligible pregnant women were randomly assigned to the intervention or non‐intervention groups using a randomization sequence, which was computer generated utilizing a random sequence generator (RANDOM ORG) that employed a simple randomization procedure. Respondents, health workers and research assistants were masked to group assignments.Results: The trial was completed with 530 women enrolled in each group. Participants were analyzed as originally assigned (intention to treat). For the primary outcome, the percentage of trial participants who attended the antenatal clinic with their partners were 16.2% (86/530) and 14.2% (75/530) in the intervention and non‐intervention groups, respectively (OR = 1.2; 95% CI: 0.8, 1.6). For the secondary outcome, most of the 161 male partners attended the antenatal clinic; 82 of 86 (95%) in the intervention group and 68 of 75 (91%) in the non‐intervention group were tested for HIV (OR = 2.1; 95% CI: 0.6 to 7.5).Conclusions: The effect of the intervention and the control on couple antenatal attendance was similar. In addition, the trial demonstrated that a simple intervention, such as a letter to the spouse, could increase couple antenatal clinic attendance by 10%. Significantly, the majority of male partners who attended the antenatal clinic accepted HIV testing. Therefore, to further evaluate this simple and cost‐effective intervention method, adequately powered studies are required to assess its effectiveness in increasing partner participation in antenatal clinics and the programme for prevention of mother to child transmission of HIV.Trial Registration: ClinicalTrials.gov Identifier: NCT01144234.

22 February 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
FGfor the PROMISE- EBF Study Group
for the PROMISE- EBF Study Group
VNVictoria Nankabirwa
Victoria Nankabirwa
JTJames K Tumwine
James K Tumwine
PMProscovia M Mugaba
Proscovia M Mugaba
Thorkild TylleskärThorkild Tylleskär
Thorkild Tylleskär
HSHalvor Sommerfelt
Halvor Sommerfelt
Data on non-specific effects of BCG vaccination in well described, general population African cohorts is scanty. We report the effects of BCG vaccination on post-neonatal infant and post-infancy mortality in a cohort of children in Mbale, Eastern Uganda. A community-based prospective cohort study was conducted between January 2006 and February 2014. A total of 819 eligible pregnant women were followed up for pregnancy outcomes and survival of their children up to 5 years of age. Data on the children’s BCG vaccination status was collected from child health cards at multiple visits between 3 weeks and 7 years of age. Data was also collected on mothers’ residence, age, parity, household income, self-reported HIV status as well as place of birth. Multivariable Cox proportional hazards regression models taking into account potential confounders were used to estimate the association between BCG vaccination and child survival. The neonatal mortality risk was 22 (95% CI: 13, 35), post-neonatal infant mortality 21 (12, 34) per 1,000 live births and the mortality risk among children between 1 and 5 years of age (post-infancy) was 63 (47, 82) per 1,000 live births. The median age at BCG vaccination was 4 days. Out of 819 children, 647 (79%) had received the BCG vaccine by 24 weeks of age. In the adjusted analysis, the rate of post-neonatal death among infants vaccinated with BCG tended to be nearly half of that among those who had not received the vaccine (adjusted HR: 0.47; 95% CI: 0.14, 1.53). BCG vaccination was associated with a lower rate of death among children between 1 and 5 years of age (adjusted HR: 0.26; 95% CI: 0.14, 0.48). The risk of early childhood death in Mbale, Uganda is unacceptably high. BCG vaccination was associated with an increased likelihood of child survival.

15 January 2013 in African Health Sciences
Verified
Journal Article
Open access
PDF file
JTJk Tumwine
Jk Tumwine
KVK Vandemaele
K Vandemaele
SCS Chungong
S Chungong
MRM Richer
M Richer
MAM Anker
M Anker
PSPs Spencer
Ps Spencer
Clinical and epidemiologic characteristics of nodding syndrome in Mundri County, southern Sudan

24 September 2010 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
JNJane S Nakawesi
Jane S Nakawesi
EWEric Wobudeya
Eric Wobudeya
GNGrace Ndeezi
Grace Ndeezi
EMEdison A Mworozi
Edison A Mworozi
JTJames K Tumwine
James K Tumwine
Rotavirus remains the commonest cause of severe dehydrating diarrhea among children worldwide. Children in developing countries die more because of several factors including poorer access to hydration therapy and greater prevalence of malnutrition. Hitherto, the magnitude of rotavirus disease in Uganda has remained unknown. This study was therefore done to determine the prevalence and factors associated with rotavirus infection among children aged 3-59 months admitted with acute diarrhea to paediatric emergency ward of Mulago Hospital, Uganda

2 February 2011 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
EHElin Hestvik
Elin Hestvik
JTJames K Tumwine
James K Tumwine
Thorkild TylleskärThorkild Tylleskär
Thorkild Tylleskär
LGLena Grahnquist
Lena Grahnquist
GNGrace Ndeezi
Grace Ndeezi
EOEdda Olafsdottir
Edda Olafsdottir
Calprotectin is a calcium and zinc binding protein, abundant in neutrophils and is extremely stable in faeces. Faecal calprotectin is used as a non-specific marker for gastrointestinal inflammation. It has a good diagnostic precision to distinguish between irritable bowel syndrome and inflammatory bowel disease. Studies have established normal concentrations in healthy children; all these studies have been performed in high-income countries. The objective of this study was to determine the concentration of faecal calprotectin in apparently healthy children aged 0-12 years in urban Kampala, Uganda.